Cost-Utility of Anti–Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2020
Source ID
10.1016/j.oret.2020.09.017

Entities

People

  • Allister Gibbons
  • James Lin
  • William E. Smiddy

Organizations

  • National Institutes of Health
  • Research to Prevent Blindness
  • United States Department of Defense